Silverfin false false 31/03/2024 01/04/2023 31/03/2024 Dr A F Leite 09/03/2020 31 July 2024 The principal activity of the Company during the financial year was that of a holding company. 12506860 2024-03-31 12506860 bus:Director1 2024-03-31 12506860 2023-03-31 12506860 core:CurrentFinancialInstruments 2024-03-31 12506860 core:CurrentFinancialInstruments 2023-03-31 12506860 core:ShareCapital 2024-03-31 12506860 core:ShareCapital 2023-03-31 12506860 core:RetainedEarningsAccumulatedLosses 2024-03-31 12506860 core:RetainedEarningsAccumulatedLosses 2023-03-31 12506860 core:CostValuation 2023-03-31 12506860 core:CostValuation 2024-03-31 12506860 bus:OrdinaryShareClass1 2024-03-31 12506860 bus:OrdinaryShareClass2 2024-03-31 12506860 2023-04-01 2024-03-31 12506860 bus:FilletedAccounts 2023-04-01 2024-03-31 12506860 bus:SmallEntities 2023-04-01 2024-03-31 12506860 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 12506860 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 12506860 bus:Director1 2023-04-01 2024-03-31 12506860 2022-04-01 2023-03-31 12506860 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 12506860 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 12506860 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 12506860 bus:OrdinaryShareClass2 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12506860 (England and Wales)

AFL HEALTH LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2024
Pages for filing with the registrar

AFL HEALTH LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2024

Contents

AFL HEALTH LIMITED

BALANCE SHEET

As at 31 March 2024
AFL HEALTH LIMITED

BALANCE SHEET (continued)

As at 31 March 2024
Note 2024 2023
£ £
Fixed assets
Investments 3 50 50
50 50
Current assets
Debtors 4 111,285 63,098
Cash at bank and in hand 102,261 156,250
213,546 219,348
Creditors: amounts falling due within one year 5 0 ( 10,413)
Net current assets 213,546 208,935
Total assets less current liabilities 213,596 208,985
Net assets 213,596 208,985
Capital and reserves
Called-up share capital 6 150 150
Profit and loss account 213,446 208,835
Total shareholders' funds 213,596 208,985

For the financial year ending 31 March 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of AFL Health Limited (registered number: 12506860) were approved and authorised for issue by the Director on 31 July 2024. They were signed on its behalf by:

Dr A F Leite
Director
AFL HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
AFL HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

AFL Health Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 246 High Street, Exeter, EX4 3NZ, England, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 0 0

3. Fixed asset investments

Other investments Total
£ £
Cost or valuation before impairment
At 01 April 2023 50 50
At 31 March 2024 50 50
Carrying value at 31 March 2024 50 50
Carrying value at 31 March 2023 50 50

4. Debtors

2024 2023
£ £
Amounts owed by Group undertakings 104,218 63,098
Other debtors 7,067 0
111,285 63,098

5. Creditors: amounts falling due within one year

2024 2023
£ £
Other creditors 0 10,413

6. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
120 Ordinary shares of £ 1.00 each 120 120
30 Ordinary A shares of £ 1.00 each 30 30
150 150